2m 2m 2m 2m 2m 2m 2m
GEOVAX LABS (GOVX)
NASDAQ
$0.66+$0.009 (+1.46%)
Price as of Aug 21, 2026 7:54 PM EDT- $3.4MMarket Cap
- -96.63%1-Year Change
- BiotechnologyIndustry
GEOVAX LABS (GOVX)
$0.66+$0.009 (+1.46%)
GOVX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.65 | ||
Change | +$0.04 (+7.24%) | ||
Open | $0.63 | ||
High | $0.66 | ||
Low | $0.61 | ||
Previous Close | $0.60 | ||
Volume | 645,481 | ||
30-Day Average Volume | 767,674 | ||
1-Week Change | -10.08% | ||
1-Month Change | -35.12% | ||
1-Year Change | -96.63% | ||
3-Year Change | -99.68% | ||
5-Year Change | -99.97% | ||
Fundamentals | |||
Shares Outstanding | 5.2M | ||
Total Assets | $4.6M | ||
Market Cap | $3.4M | ||
Enterprise Value | $220,454.00 | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$4.4M | ||
Free Cash Flow | -$3.7M | ||
EBIT | -$4.4M | ||
EBITDA | -$4.4M | ||
Net Working Capital | $1.5M | ||
EPS | -$0.97 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 01/12/2026 | ||
Earnings & Revenue